Díaz Pinzón, Jorge EnriqueFolegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396(10249):467-478. doi:10.1016/S0140-6736(20)31604-4 2. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman S, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N. Engl. J. Med. 2020;383(27):2603–2615. doi:10.1056/NEJMoa2034577 3. Coronavirus Resource Center. Covid-19 data [Internet]. Johns Hopkins University & Medicine; 2022 [cited 2021 noviembre 3]; Available from: https://coronavirus.jhu.edu/ 4. Dhar MS, Marwal R, Radhakrishnan VS, Ponnusamy K, Jolly B, et al. Genomic characterization and Epidemiology of an emerging SARS-CoV-2 variant in Delhi, India. Science. 2021;374(6570):995-999. https://doi.org/10.1101/2021.06.02.21258076 5. Ritchie H, Mathieu E, Rodés-Guirao L, Appel C, Giattino C, Orti....
,
2022
